An international comparative analysis of public reimbursement of orphan drugs in Canadian provinces compared to European countries

• Published in: Orphanet Journal of Rare Diseases
• Main Authors: Leanne Marie Ward, Alexandra Chambers, Emine Mechichi, Durhane Wong-Rieger, Craig Campbell
• Format: Article in Journal/Newspaper
• Language: English
• Published: BMC 2022
• Subjects: Rare disease; Orphan drugs; Reimbursement; Regulatory approval; Funding decisions; Patient access; Medicine; R; British Columbia; Canada; Newfoundland
• Online Access: https://doi.org/10.1186/s13023-022-02260-6; https://doaj.org/article/191f557e1b3e49a697452c18dfb379f2

Abstract Background The Canadian government has committed to developing a national strategy for drugs for rare diseases starting in 2022. Considering this announcement, we conducted a comparative analysis to examine patient access to therapies for rare disease in Canada relative to Europe and the U....